|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Aimmune Therapeutics, Inc. (AIMT) |
|
|
$34.49 0.00 (0.00%) as of 4:30 Mon 10/12
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
63,299,000 |
| Market
Cap: |
2.18(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$34.49 - $34.49 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2020-01-02 |
4 |
OE |
$19.63 |
$392,600 |
D/D |
20,000 |
41,250 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2019-12-26 |
4 |
AS |
$33.03 |
$330,322 |
D/D |
(10,000) |
45,668 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2019-12-26 |
4 |
OE |
$12.95 |
$129,500 |
D/D |
10,000 |
55,668 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2019-12-09 |
4 |
AS |
$30.04 |
$600,716 |
D/D |
(20,000) |
21,250 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2019-12-09 |
4 |
OE |
$11.45 |
$229,000 |
D/D |
20,000 |
41,250 |
|
- |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2019-09-18 |
4 |
B |
$22.57 |
$34,977 |
D/D |
1,550 |
33,574 |
2.74 |
- |
|
| Enright Patrick G |
Director |
– • – |
2019-09-17 |
4 |
A |
$22.34 |
$279,216 |
D/D |
12,500 |
45,561 |
|
- |
|
| Iwicki Mark T |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
39,567 |
|
- |
|
| Falberg Kathryn E |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
65,192 |
|
- |
|
| Enright Patrick G |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
33,061 |
|
- |
|
| Seltzer Stacey Denenberg |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
10,221 |
|
- |
|
| Mcdade Mark |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
26,852 |
|
- |
|
| Behar Gregory |
Director |
– • – |
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,442 |
10,192 |
|
- |
|
| Dallas Jayson Donald Alexander |
President and CEO |
• • – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
98,650 |
|
- |
|
| Adelman Daniel C Md |
Chief Medical Officer |
• – – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
11,875 |
21,250 |
|
- |
|
| Rozenman Mary M. |
See Remarks |
• – – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
14,504 |
|
- |
|
| Bjerkholt Eric |
Chief Financial Officer |
• – – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
13,125 |
32,857 |
|
- |
|
| Sheehy Douglas T. |
See Remarks |
• – – |
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
45,668 |
|
- |
|
| Oxtoby Andrew |
Chief Commercial Officer |
• – – |
2019-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
12,000 |
|
- |
|
| Nestle Us Holdco, Inc. |
10% Owner |
– – • |
2018-12-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,727,113 |
|
- |
|
| Nimco Us, Inc. |
10% Owner |
– – • |
2018-11-28 |
4 |
B |
$30.27 |
$98,000,003 |
I/I |
3,237,529 |
11,727,113 |
1.5 |
- |
|
| Barrowcliffe Susan E. |
General Manager, Europe |
• – – |
2018-11-19 |
4 |
S |
$30.04 |
$1,201,600 |
D/D |
(40,000) |
9,375 |
|
- |
|
| Barrowcliffe Susan E. |
General Manager, Europe |
• – – |
2018-11-19 |
4 |
OE |
$3.02 |
$120,880 |
D/D |
40,000 |
49,375 |
|
- |
|
| Dallas Jayson Donald Alexander |
President and CEO |
• • – |
2018-11-19 |
4 |
B |
$27.56 |
$100,587 |
D/D |
3,650 |
63,650 |
2.81 |
- |
|
| Falberg Kathryn E |
Director |
– • – |
2018-11-01 |
4 |
GA |
$0.00 |
$0 |
I/I |
69,894 |
69,894 |
|
- |
|
268 Records found
|
|
Page 4 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
